TREM2 Targeted 89Zr-ImmunoPET Visualizes Microglial Activation during the Inflammatory Response
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Neuroinflammation is mainly mediated by activated immune cells such as microglia and astrocytes, and is a key driver of neurodegenerative and neurological diseases. Triggering receptor expressed on myeloid cells 2 (TREM2), which is selectively expressed on microglia in the central nervous system, has emerged as a promising target for assessing microglial activation. We developed an 89 Zr-labeled bispecific anti-TREM2/anti-transferrin receptor antibody ( 89 Zr-T2BA). TREM2 specificity was assessed in vitro in wild-type (WT) and TREM2-overexpressing (TREM2 OE) HEK293T cells. In vivo specificity and diagnostic performance were evaluated in healthy WT and TREM2 knockout (KO) mice, and in a systemic lipopolysaccharide (LPS)-induced neuroinflammation model. Microglial activation and peripheral immune infiltration were cross-validated by flow cytometry, Western blotting, and immunohistochemistry. 89 Zr-T2BA showed selective uptake in TREM2 OE cells and clearly distinguished WT from KO mice. Importantly, 89 Zr-T2BA detects LPS-induced neuroinflammation without confounding peripheral immune infiltration. These findings position TREM2-targeted ImmunoPET as a promising microglia-specific imaging strategy to detect the inflammatory response in the brain.
